Vita means life. It's also our platform for sharing the stories of biotech's promise to patients and public health.
CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Learn more by visiting each section.
Biotechnology leader CSL Behring offers the broadest range of quality plasma-derived and recombinant therapies in our industry.
Derived from the expression 'securing health for all of us', CSL Seqirus is one of the world's largest influenza vaccine providers.
R&D focuses its expertise on four strategic platforms: plasma protein technology; recombinant technology; cell and gene therapy; and vaccines technology.
One of our core values at CSL is Innovation. We support collaborative innovation through the endowment of awards and grants to researchers around the world.
As part of our broader sustainability strategy to build a more sustainable future, we've committed to a 40% reduction in absolute Scope 1 and 2 emissions by 2030.
Along with our sustainability strategy, CSL’s community contribution framework helps deliver on our Values and support execution of our 2030 strategy.
At CSL, Diversity, Equity, and Inclusion (DEI) is at the core of our mission and who we are. It fuels our innovation day in and day out.
Whether you are early in your college education or recently completed your degree, it's never too soon to consider CSL for your Promising Future!
Health equity should include those who live with rare conditions, says Peter Saltonstall, President and CEO of the National O…
The Schwartz Center for Compassionate Healthcare honors top caregivers and offers insights in how to lead with compassion for…
March 30 is Doctor’s Day. Hear from three CSL doctors about how physicians and patients can build a productive partnership.
Gene therapies have the potential to transform a patient’s quality of life. But how will a complex network of stakeholders fi…
The 27-year-old lives with von Willebrand Disease, a bleeding disorder it took years to diagnose. He makes regular visits to …
For the second time in four months, the global biotech company is launching a new manufacturing facility with expanded capaci…
CSL Behring employees in Marburg, Germany, recently took advantage of a voluntary functional movement analysis, which assesse…
We asked people who know bleeding disorders best to tell us what these conditions are like in real life for those who live wi…
As hemophilia patients live longer lives, watch out for these three health conditions, according to a recent Hemophilia Feder…
Americas
Asia Pacific
Middle East
Europe